Hey everyone meet trey here. Ah, no, i'm just playing i'm just playing, but you got it. You got ta have some fun. What is up? Everybody welcome to trace trades.

We have technical analysis and different stocks in the stock market, as well as potential buy holders, sell opinions on these given stocks like the purpose by saying that i'm not a financial advisor nor expert so take what i say: the green assault, let's get into the video Today, my friends we're looking at five different stocks, we're gon na jam-pack. This thing full of good information, five stocks that i think have some solid, solid potential, we're gon na run through a bunch of different things. There will be time stamps and chapters on the video. If you'd like to skip ahead, please feel free to do so, but we're gon na look at the fundamentals of each of these companies right we're gon na look at different news catalysts that could drive the price action, we're looking at some different institutional buyers that have Stepped in here, some different statistical numbers in regards to what could come from some of the price action you know regarding those numbers and then the meat potatoes, which is the chart set up.

So i've got a couple. Different indicators pulled up. I'm gon na get rid of this fibonacci real, quick just to give you what they are. This is the rsi down here the relative strength index, anything over 70's overbought.

Anything under 30 is oversold. This gives you an idea of both bullish and bearish momentum on a stock and its price action uh, and then we've got the 200 dma, which is the exponential moving average, as this purple trend line and the 15 day ma, which is the moving average. As this blue trend line and we're going to talk about those, the 200 ema is the exponential moving average. This is a price, action-based valuation trend line over a 200-day moving period, which gives us a macroscopic perspective of the overall price action.

Then we've got the 15-day ma, which is a moving average. Some brokers accounts call this the sma, the simple moving average. They are one in the same, but this is a price, action-based valuation trend line over a 15-day moving period, which gives us a microscopic perspective of price action. We use these side-by-sides, so we can predict upcoming, uh, breakouts or breakdowns the best possible entry points and uh.

You know exit points right so that we can make the most bang for our buck. Uh we're gon na drop. Some different entry points, some different uh. You know, fibonacci retracements give an idea, both bullish and bearish strength of a chart.

Right, we've got quite a bit to talk about here, so let's just get into the video, so we're gon na start off here with agtc. What is the company? Why should you care what what do they do? Bloodgenetics technology corporation is a clinical stage. Biotech company the company develops gene therapy products designed to manage the lives of patients with severe diseases and ophthalmology. As of march 31, 2016 as product candidates included uh treatments for x-linked retinol chises over two forms of achromatopsia and x-linguatinous pigmentosa.

As of march 31, 2016. The company was engaged in developing three discovery programs targeting three indications based on its adeno-associated virus vector technologies. Xlrss is an inherited retinal degenerative disease caused by mutations in the retinal kinesis. Gene achromatopsia is an inherited condition that is associated with visual acuity loss, extremely sensitivity resulting in daytime blindness and reduced or complete loss of color discrimination.

Achromatopsia is caused by mutations in any of several genes. The company is also developing alpha-1 anti-trypsin deficiency. Now the basic premise of this company, where the where the value lies right, is essentially in the potential for them to alter gene mutations right so being able to find the source in the mutation that is causing specific uh eye illnesses, eye diseases that are causing blindness Daytime blindness color loss right whatever it may be, they're trying to find the exact coding within the the genetic breakdown that is causing that mutation so very, very interesting. It honestly hits a little bit home to me because i have this eye condition called you know: bilateral anterior uveitis.

I actually had a flare up here today, which wasn't too bad. Luckily, i've got some eye drops on tap steroid eye drops that take care of that, but if they could, you know, get down to the coating and the source of the issue that would be monumental. So they've got a couple different products here in the pipeline. Uh pipeline specifically talking about products that need fda approval.

They can commercialize right. They've got five here two here in one here, so we've got xlrp achm, optogenetics dry amd, star guards right, and these are all ocular. Basically products. We've got the neurogen neurodegenerative right, which is basically neurological breakdowns and degeneration of of of the neuron fcd and als, and then we got autology uh non-syndromic hearing loss.

So this hearing loss is separate from that uh that overall eye condition right, but they've got quite a few products in the pipeline which we are expecting eventual fda approval on right and since they've got so many products in the pipeline, you can expect different news catalysts To come out periodically through time, so that is very significant. That is something that i want to point out, which could act as an upcoming news catalyst. Personally for me, i think this is a great long-term hold stock. I do currently have call options on my weibull account and my other brokerage account.

I have about two thousand dollars worth of agtc and i do not plan on selling it anytime soon, so great company with uh some huge growth potential. They do end up getting these. These fda approval on on all these different products right. A downside is, since this is kind of a biopharmaceutical type company right, you're, expecting a news catalyst and that, if the approval to go well in order for the price to climb.

But there are a couple different positive things that i do want to point out to you right. I want to be transparent as possible. Show you the pros and the cons and some of the pros. Uh are the price targets on this.

So if we just look at agtc um price targets, just take a quick peek, we can just take a peek at uh. I should i just i type in ajtc analyst uh price targets. There are price targets between 30 and 35 dollars which are monumental. You can see right here that roth capital boosted their price target from 30 to 35 dollars.

We've got 18 to 24.. One has it at 11 here one has it at 750, but they are all buys they're all buy ratings, which is very significant. This uh february. Second, one by hc wainwright: that was a recent boost, so you want to really pay attention to that, as well as institutional buying.

We currently have 42.46 of the total shares outstanding, which is 42.6 million uh being held by institutions. That is a very, very, very large number. You 100 want to pay attention to where institutions are putting their money because they're not going to put money into a penny stock, they don't think it's going to grow most recent filings. We've got four companies that uh that bought into the company, not necessarily on the 12th, but were filed on the 12th, with just under 20 of the total institutional ownership coming in in the past two weeks, which is very, very significant.

That is a huge huge number. Keep that, in the back of your mind, then i've got to pull up on ortex as well. Just show you some different uh numbers in regards to what the situation looks like right now, right, analysts are saying: there's a return. Potential of 121.37 percent five buy ratings, average price target of 15.56 and then the utilization rate, which is the current short interest on the stock, not very high.

We've got 19.21 of the total utilization coming in on the stock, meaning that out of 100 total lendable shares 19 of that is currently being held, meaning that around 81 of the total shortable shares are available for lending. So not a lot of people are betting against the stock, which does make a lot of sense, very low interest rate cost to borrow meaning 1.02 annually, not a very high number days to cover also pretty decently low days to cover signifying you know the difficulty of A short to cover their position, there's not necessarily a time period in which shorts have to cover right that just states that the higher the days to cover right, the more difficult it is for shorts to be profitable on a stock. So that is what the current situation looks like. I do have a recent article pulled up right here: applied genetics, tech, uh, up 37.6 percent, since smart trend, uptrend calm, i'm just going to read the first little bit here.

Smart smart trend identified an uptrend for applied genetic uh on february 5th, 2021 at 5, 11 cents. In approximately two weeks, the plyogenic has returned 37.57. As of today's recent price of 703. over the past year, applied genetics traded in a range of man.

What a stupid typo a bunch of weebs, a bunch of weebs uh from zero dollars to 966 and now we're at zero dollars in the last five trading sessions, the 50-day moving average has climbed four percent, while the 200-day ma has riven 1.2. So i see a lot of positive signs here. If we just look at the chart set up here, real quick, how things are looking right now in terms of pullback and healthiness of the chart right, i'm gon na drop a fibonacci retracement. This essentially just tells you the strength of an overall chart setup.

We can see that the overall chart setup is not terrible. We ideally look for a 50 retracement. We got about 61.8. Anything about 50 shows a lot of strong buying presence, but do keep in mind.

This ran up a huge huge amount from 3.82 cents and in fact, if you drop a fibonacci retracement from the floor down here, you're looking at a much healthier retracement of about 50. If you're, looking at a more macroscopic perspective, if you're looking to establish a position in this stock, i do think that now is a pretty solid time to buy, and i say that for a couple different reasons right. So if we just look at some different trends that we're seeing right here, we can see that there was a downward uh, a descending level of resistance, which we have in fact broke. All that we're looking for now is that that wide range candle bar to break above that descending level of resistance.

But nonetheless it does look like. We finally found a floor, and i say that also because we have this descending level of support which is no longer being respected. You see that break above that decent level of resistance, we're no longer following that downward channel right. So to me, this signifies the only thing that i'm looking for to confirm that we are out of this.

This price zone is if we get a wide range candle, which is a candle that covers a lot of price action right to con, to completely break above that descending level of resistance. So it looks something like uh like this: this kind of candle to break above that uh that level of uh resistance to me would signify. We have in fact found the bottom. So what is a good entry point for this? If you were looking to establish a position, i do think somewhere around what would be six dollars and 84 cents and between uh here at about seven dollars is gon na treat you pretty well as a solid entry point, i do anticipate you're gon na see this Run for quite a bit of time, as i mentioned, i do have some call options on this stock.

I'm gon na pause the video quick just to show you to be trans okay, so, as i had mentioned, i do have some call options on them. I do have four call options: uh i bought them all at a dollar, which means i bought. I i purchased each option for 100 you're paying a dollar per share and you buy 100 shares per option. So 400 is my initial cost average.

I'm currently setting up about 17.5 percent at the height, i was up nearly 200 and i did not sell because i think there's still upside remaining with this stock, so keep that in the back of your mind, that is the current position. I do think the solid entry point is gon na be between that six six dollars. Eighty four cent mark and seven dollars and i would watch for a long-term hold play in this stock or, if you'd like to play some call options. We do know that there is some upcoming known news catalyst.

So if we just look at the investors, relations right and just take a quick peek at events and presentations, we can see that they're presenting on both monday and wednesday february 22nd and the 24th starting at 1-4 p.m until uh 3. 30 p.m. You know here on the 24th, so a couple different news catalysts that could drive the price action, which is why i feel pretty comfortable with some call options. If we look at the overall interest in call options, it is pretty decently high in terms of puts not a ton of puts right.

So there's not a lot of people bidding against the stock in in you know, comparison to the call options. We've got quite a few uh call options at that 10 strike 6 300 total, which is pretty solid. You could buy those for a lot cheaper than i ended up purchasing my 7.5 call options at 80 cents, so looking pretty solid there for agtc next, since onyx sensionix. I do think this is a long term potential stock.

I personally have a couple different call options on this portfolio and my other portfolio. I've got a long term position with about two thousand five hundred dollars established in synsonics. I have four call options as well as 60 shares here, and i've got quite a few couple. Hundred shares over in my other portfolio, what do they do? What is the why? Why should you care sensonic's always incorporated as a medical technology company, the company focuses on design, development and commercialization of glucose monitoring systems.

The company operates through glucose monitoring system segment. It offers a continuous glucose monitoring, cgm system ever since, which has designed an implantable cgm system designed to continually measure glucose levels in people with diabetes. The company's eversend system consists of components such as a sensor which is inserted subcutaneously in the upper arm by a healthcare provider, an external removable, smart transmitter that receives assesses and relays the data from the sensor and also provides vibratory alerts in a mobile application that receives Data from the transmitter and provides real-time glucose readings alerts and other data on the user's mobile device, such as a smartphone, apple, watch or tablet. There are a couple different things that i see as potential here with sensonics, so we're gon na start off here.

To show you guys their website here, real quick, we're gon na show you their eversense system so as it sits right now, this company, basically the premise and the long-term potential for growth - lies in the commercialization of the 90-day system, which they already are selling right and Then they're in the process of getting fda approval, essentially on the 180-day cgm system, which is already commercialized in europe, basically trying to get that commercialization across the united states across the world right and they have a 360 day system which they are expecting to work through. Throughout the next one to two years, so there's a lot of potential here with uh with ever since, with with synsonics and what you're. Basically, betting on, i wouldn't say betting on, but taking an educated guess at fundamental analysis and due diligence on is that they are a big player in a competition to the ultimate uh system here, which is dexcom. So if we just check out dexcom here, real quick dexcom has a g6 cgm system and the the major difference to me is that, yes, this is a continuous glucose monitoring system, but they only monitor glucose levels for a maximum of 10 days.

So if they get approval, i already - i already think that the sensonics you know technology they're using right now that 90 day system is superior to the dexcom system right because it's inserted subcutaneously into the skin, meaning under the arm as comparison to the dexcon system. Dexcom system, which is uh, you know just a patch that you're basically placing any somewhere on the abdomen or on the body right. So it is a little more invasive right, but this is life-changing stuff for diabetics right. There are instances where, if you can't get a finger prick or you can't scan you know, maybe have a malfunction with the with the dexcom system.

It could be life or death, so very, very significant. I think there's a lot of solid potential here. Let me just take a quick peek at the system, as i mentioned, prior you've got the sensor, which is inserted subcutaneously the transmitter, which directly messages your uh, your data over to your mobile, app to a smart watch to a tablet to an ipad whatever it may Be right, so you can continuously monitor your glucose levels. Now, let's say you don't have your phone on? You don't have any technology on you, that's okay, because the sensor will actually give you vibratory alerts when you need to monitor and take care of your overall glucose levels.

So there's a lot of positive things that i think are capable of happening here with the ever. Since system and with sensonics and if they end up getting, you know approval for that 180 day, cgi cgm system by the fda, which we are expecting sometime within the next. You know a couple weeks to months right there they said sometime in early 2021, that is gon na, be a major major catalyst. That's gon na drive the price action up on this exponentially.

I personally think this has a lot of potential to be an 80 stock. Uh by the end of the year this year, if they end up capitalizing on it, getting fa approval on that 188 system, so very, very solid potential here in terms of sensonics. If we look at the overall institutional ownership, i'd say anything over 10 is significant. We do have 19.24 percent 71.6 million shares as comparison to the shares outstanding of 372 000 total in terms of recent buyers.

We had four companies step into this on february 16th, not necessarily mean they bought on the day right, but it was filed on that date. Right: we've got 4.75, 11.5, 3.12 and 5.89, so a lot of companies are stepping into this. As of late, you want to pay attention to where big money's going and the more recent that these guys bought into the company the more significant the information to you right. So you want to pay attention to the most relevant information in terms of uh who's, who's buying into a stock news, catalyst right, fundamental value.

That is significant, so there's some big players in the game. I think there's some significant upside in terms of sensonic's potential. We do have a press release here, so synthetics holdings incorporated is also scheduled. Your fourth quarter in full year 2020 earnings release and conference call on march 4th 2021 at 4 30 pm eastern time, so that could act as another solid uh news, catalyst right.

We are expecting, i shouldn't say we are expecting, but you are hoping that the earnings call is positive, which should drive the price action. Now you can point out a couple different ways. If you want to play this off short term, you could buy another stock. Anticipating there's going to be some hype, leading to that earnings call right.

There typically is and a example of that to me would be agtc. You can see an example of that right here on the charts right. They had an earnings call this day the price action drove up, even though it's negative right just because of hype and anticipation. So there's uh there's a couple different ways.

You can play that off both short term and long term right, but that is something that i want to bring to you guys attention. Last thing i want to show you is ortex. There is a pretty decent amount of short interest on on sensonics. We've got 78.61 percent total utilization, meaning that there's only about 22 percent of total lendable short shares available at the moment, which is not very high.

That's a pretty low amount, which means there is short term potential for a squeeze cost to borrow - is also decently high. That means it's 16.42 annually right. So that means that the the risk involved for shorts to hold a position in the stock is higher. That's why the cost of bar will go up because brokerages and clearing and clearing houses will say hey.

This is a risky short you're. Gon na have to pay us more interest if we're gon na lend you this money. So that's good to see as well and the days to cover anything over one, i think is significant, which means that currently, it is tough for shorts to cover their position. Their positions that doesn't necessarily mean that shorts need to cover it right by that uh 1.55 days.

Shorts can hold their positions pretty much as long as they want without getting a mark as long as they don't get a margin call. I should say we all know what happens but uh, essentially that is that is just saying how difficult that is going to be for shorts to come out profitable on their position in the stock. So a lot of good things happen here. We've got some upcoming known catalysts.

We've got that that uh, that earnings release, which should be pretty solid. If we look at their events and publications right their upcoming events, we know they have two right, so we've got their fourth quarter, 2020 earnings and then thursday. This week, we've got the 10th annual svb lyric global healthcare conference, there's speculation and rumor that they're going to announce approval or or denial of that 180-day cgm system. If it is approved, my friends that is going to be a freaking grand slam play for sensonics - and i am so freaking pumped for uh for this stock, so that is looking very, very solid.

I i'm very excited about sinsonics and, as i said, i do have a position in this stock, so in terms of technical setup, we're just going to show you guys this. On the one month chart, we've got a huge gap here between the 15 m and the 200 dma saying that this is in fact, in bullish territory on the rsi sitting at 50, uh has been consolidating for a little while, in my personal opinion, consolidation does favor Buyers so longer this trades sideways, the more confirmation and the more buyers are gon na have step into this. Just based on the overall price action we're seeing, we got ta george dabia george, w being a double bottom. Double bottoms are bullish in nature.

That typically indicates an upcoming run right and if we just take a peek at previous price action, the last time we had a double bottom. In fact, we had a triple bottom, two george w, as essentially we saw a huge huge run in price action. So if this is any sort of confirmation as to the possibility of what could come, that looks very solid, and this looks like a very solid entry point right. So you've been consolidating for about two days.

Had a couple. Ups had a couple downs, but a solid buying point for me is: if you see this, come back down to this ascending level of support and you can get an entry at four dollars and fifty cents that is going to treat you extremely extremely well. So i'm gon na level this off at about four dollars and fifty cents. Don't look for that exact number right if you come within five cents, ten cents, that's not bad right! So if you get this at 460, you want to hold this long term.

I don't think that's gon na treat you bad you wan na get the short term. Obviously the lower you can get the better entry point. You can get the better off you're gon na be, but i really think you're gon na be leaving some briefcases on the table if you chase a bag on this. I really do think this is a long-term position stock, so very, very solid in nature.

On the charts, we're looking very, very bullish, nice, consistent volume, which makes this predictable. In fact, the last two days of consolidation, the volume has been down which to me signifies that people aren't selling their positions there. In fact, holding right, lower volume days does decrease the volatility if it is consolidating which i do not mind at all. There's a lot of solid confirmations here on the chart that are saying to me that this is a solid, solid setup for sensonics.

Next is going to be mvis. This is my baby. I love my girl mavis dude, what a positive positive stock, absolutely love microvision. So if we just look at what they are, what the y is microvision incorporated is a developer of laser beam scanning technology, the company markets, its technology under the brand name picop.

It has developed scanning technology that can be used in products for interactive projection, consumer light detection, ranging automotive, lidar and then augmented into mixed reality, picops scanning technology that can be adopted by its customers to create high resolution miniature projection and three-dimensional sensing and image capture solutions. They use laser diodes as the light source. The company offers key components for inclusion in its scanning engine, including its micro electrical mechanical systems, which is mems and application. Specific integrated circuits, the company's blp scanning technology incorporates its expertise in two-dimensional, mems, lasers, optics and electronics to create a smaller form, uh factor scanning engine with lower power needs than many other technologies that projects, video and still image to capture three-dimensional data.

So essentially, this is kind of like i don't want to compare to tesla because that's a little bit of a stretch, but this is, in my eyes the technology side of things, a tesla in terms of the amount of technology and things that they offer right. They're, a disruptor these guys are a absolute disruptor, so i'm going to take a quick peek at their website. I want to show you some of the technology why i think there's such long-term potential for this company to be completely transparent. This is my largest stake that i have in my portfolio.

I don't have them on weeble, but in my other brokerage account, i've got a hefty hefty stake in microvision and every opportunity that i have to add to them. I do so they've got not a million patents, but quite a few patents right and patents are a great way to give you guaranteed revenue, guaranteed growth right. So that is a very positive thing to see. They've got source coding, silicon design, hardware systems, men's optomechanical, advanced manufacturing, capital equipment right.

So these are, i wouldn't say, exciting, not sexy, but they're ways to generate revenue in ways that the company can capitalize on and kind of ladder, their way up through different. You know technology that they offer it's a snowballing effect. So since they've got so many different products that they offer, if they make revenue on one product, they can work on developing another product or improving another product, and it just keeps bouncing back and forth back and forth and it's a way to guarantee. They continue to generate revenue, they've got a projection engine and an interactive projection engine.

I don't think these are super sexy either, but the the interactive projection engine is very cool because it projects straight onto a onto a desk onto a wall. You can take a shower if you want to play some candy crush, or you know, be cooking a pizza and scroll through a video right and we've got the projection engine which is not interactive, so they're both potentially the same thing except this one. You can actually use similar to an ipad. You've got the consumer 3d auto sensor, which is great for smart home applications, security, automation, high resolution, low latency 3d ladder sensor.

The projection engine for head mounted displays, which is similar to some iv as technology that these guys offer as well right, which is utilized by the aviation sector of the military, the army right. They use this to help navigate the skies more freely. So they can. You know accomplish the mission they're also in the works of developing uh ground troops, uh technology that utilizes the same tech right so infantrymen, armormen field artillery guys air defense artillery guys myself included in that equation.

This time on air defense, artillery officer right they'd be able to utilize this technology to help navigate the battleground more freely so very interesting ar mr and vr technology. Another thing that we're most excited about is the automotive 3d ladder sensor. This is exciting because we've got joe biden in office, but it's completing uh, you know being completely apolitical and with joe biden in office, green energy sector plays or electric vehicle plays right. All that sort of stuff is going to be huge for growth over the next four years.

They are currently in the works of developing that automotive, 3d lidar sensor. A prototype came out. My friends and people went absolutely ape crazy, so that was insane there's any sort of indicator to where this stock can go in the future. I am so pumped uh for this for this presentation, which is expected to come in april.

It is already february 21st, my friend, so we are coming up very close to the day, i'm very, very excited in terms of microvisions institutional ownership. We've got 20.31 percent of the total shares outstanding being owned by big institutional companies in the the most recent institutional stakes. We've seen you know, step into microvision have not been recent they've been uh. You know, sporadically over the last couple years.

Most recent was that, as of uh 2020 march 6th, we saw awm investment step in for about four three point: four point: three percent of the total ownership in the company, so that is probably a con that i do see a microvision to be completely transparent right. You do not see a large amount of institutions that accept it as of recently, but i do think it is something that is going to change in the near future. Another thing that i think is significant is this apple is reportedly talking to lidar suppliers for itself driving vehicle project, and i think that is significant because microvision, if their lighter presentation goes well, their automotive lidar right they're going to be in prospect for a potential buyout Or an acquisition, a company acquisition - if this happens, candidates such as apple microsoft, ford, uh, all companies that are trying to get into the autonomous vehicle in the electric vehicle game. Uh they're gon na be able to negotiate with these companies and make a deal happen.

That's a lucrative process for shareholders. Shareholders will receive a cut per billion dollars in acquisition. As an example, if you were to look at, i think whole foods was bought out by amazon whole foods. Amazon buyout right there was uh.

There was 13.7 billion dollars in uh acquisition that came from that, and shareholders received a cut per billion dollars. I don't recall it off the top, so here it says right here: 42, a share in cash for the organ organic food chain, so shareholders received 42 dollars per share uh. If i was just to do some quick math, i would think that comes out to a pretty decent uh, pretty decent cut. Let me just do the math here on my phone really quick, 42 divided by 13.7 you're, looking at about three bucks per share.

So, that's not that's not bad in the least bit uh and it'd be the same prospect for microvision. Of course, the overall dollar amount that comes out of that. Nobody can say for sure. I've seen numbers float around in that seven dollar range, but it's a very lucrative process, and if that that presentation goes well, my friends, this apple deal is a big big deal, because we know that apple is trying to get into the self-driving game, so very significant.

That they are looking into those lidar suppliers. I do think that that presentation goes well. Microvision is going to be a big prospect if we look at the overall numbers on on short interest right. I do want to point this out to you.

We don't have any analyst recommendations in terms of price target. All the price action has been very very recent. I do anticipate you're gon na see some numbers in the future, but utilization is decently high. This is still pretty high shortage stock, so 70.88 utilization, meaning that there's only about 30 percent of total lendable short shares available to the market right now, right, pretty significant number.

So, even though the stock has been going absolutely crazy, these shorts are playing with fire and besides there's potential in the short term for a squeeze right. It's for some pretty solid price action, so potential there for both short-term and long-term investors costs tomorrow, not insanely high. At 7.87 percent, i do anticipate that some of these shorts have uh, you know, lost some money, the risk isn't as high since we have been. You know: dropping back a little bit pulling back a little bit dates to cover anything over one i think, is significant.

So we're getting up there, we're creeping up there in terms of how difficult it is going to be for shorts to come out of this profitable days to cover does not necessarily mean that shorts need to cover in .96 days right. It just means that hey the higher this number is, this days to cover the more difficult it is for shorts to come out profitable on their position right, so the more bullish in nature a stock will be so there's a lot of positive things. My friends in terms of what is happening here with microvision, i think, there's some solid potential with microvision, so we're going to come over here to the options, which is one thing that i do want to point out here. There's a lot of options on that 30 strike.

As of uh. You know, i think it would be march 19th in comparison to the puts not a lot of puts right. So there's a lot of people who think it's going to be very, very bullish. I do think there are far more calls than puts.

I do want to be transparent and show you both of these, but there's a lot of sentiment out there, thinking that microvision is going to be a big big player and my friends, my family. If this isn't the dirtiest double bottom george, w that i've ever seen - oh my deleo, that is beautiful, so we've got a nasty nasty double bottom here. Big fat, george w, which is a bullish indicator, typically of an upcoming, run that you're likely to see right. The volume is nice and consistent.

We've got a big gap here between the 15 ma and the 200 ema. In fact, the 15m is starting to hook out, which typically is an indicator of upcoming breakouts right. So that is a solid, and what do i mean by by hooking out right? You can see that this. This 15ma is starting to move back upwards in comparison to the 200 ema, which is moving a little bit downwards.

So that looks solid rsi had some crazy bullish movement right. We saw a lot of motion here and this is still very bullish in nature. I i feel very comfortable with where microvision is heading. I think it's possible that you see a pullback to this uh.

This ascending level of support as an entry point at 1857, but it might not happen right so if it doesn't happen, where are you looking at for a potential entry point, you're gon na be looking right here at about twenty dollars, so nineteen dollars and ninety cents Of course, don't look for that exact dollar amount right. This is a general ballpark area if you can get within 5, 10, 15, 20 cents of that. As an entry point, i think it's going to treat you pretty well, as i mentioned, i do think this is a long-term potential stock. I would not hold this.

You know just for a month or for a week or for two weeks right. I'm gon na be holding this for years and years and years to come at least before now, right until something fundamentally changes about the company so looks very bullish in nature. I love everything about what's happening here with microvision. I think it is going to continue to run and be a big player here today.

Ctrm ctrm, i'm just going to give you a quick rundown. Casper maritime is a cypress-based company. The company is engaged in the ocean transportation of dry bowl cargos worldwide through the ownership and operation of bolt carrier vessels. It also aims increases fleet through acquisitions of new and modern vessels.

Essentially, what the prospect of growth is here for ctrm is the acquisition of new vessels right, so they can continue to branch out the dry bulk cargo in which they are transporting right. The more shifts that they offer the more dry bulk cargo that they can make profit off of so i've got some different tabs pulled up here. I'm just going to find this here, really quick, caster maritime we're just going to show you their website here. So if we look at their website right and just look at the things that have happened here, they were incorporated and took ownership of its first vessel.

In 2017 they entered uh notc, the tiger caster and then the nasdaq under ctrm. They acquired four vessels here in the last four years. Five years, i should say they they caught five and as of late they've, been on a rampage in terms of acquiring new vessels. I think in the last two weeks, they've acquired three right.

So, in terms of you know, revenue, maybe right now they're putting themselves in a little bit of debt right. So you know by by purchasing these vessels, they don't have as much free cash available. Their balance sheets might not look as nice. The available cash might not be as nice.

The overall liabilities might be increasing a little bit for now, but in the long term right that is going to offer you some solid potential for ctrm. They did just acquire a new vessel. This is as of february 18th, which did drive some price action in the very very short term was kind of short-lived. To be honest, not a lot of price action happened there, but nonetheless they did acquire a new vessel.

Of course, seeking alpha wants me to get a get a subscription for their for the product, but take it for what it is. They purchased a new vessel from a third party for 14.8 million dollars, the more they acquire. These vessels, the more potential for growth you're. Going to see with ctrm - and i think it's going to be a big stock that continues to run as of now, i do think it retraced pretty well we're gon na come back to the charts here, but i do think there's still some potential upside, especially in The short term right, i don't know that i would personally hold this forever as a long-term stock.

I think the most upside probably is gon na, be the short term to midterm right, because i think there's gon na be some volatility right. If you're gon na leave a little bit of cash on the table, if you, if you sit through those swings i'll, keep you guys as up to date as i possibly can, but i do think that you're gon na see some pretty solid price action down the Road in terms of uh ctrm institutional ownership - i'm just gon na pull this up here, real quick here on fintel, i typed in the wrong thing. Obviously, institutional ownership - i'm just gon na point this out to you, so that we can look at all the different prospects that are available to us and it is 2.3 very, very low. So that is that is a con of ctrm um.

So they've got about 13.9 million shares owned by institutions out of the 608 million total available shares, but something that is positive is that uh. Maybe that number is actually even not even updated, because that's some pretty significant ownership. I do see sometimes some discrepancies between the numbers on the top here compared to the bottom, but uh. You know we'll assume the worst, we'll assume the worst and say that it's 2.3 percent right, that's worst case scenario.

Best case scenario is, is much higher than that. You've got 2 4 6 eleven, we'll just round that up to ten, so twenty one, thirty one, forty one uh we'll say: that's forty six percent institutional ownership and one of these companies that bought it was as of february 16th. That doesn't necessarily mean they bought it. That day, that's when it was filed they could have bought it much much earlier, but that is very significant information.

So i think that's something worth noting right, so recent buyers stepping into the game here. I don't think that would happen. Institutions don't buy into companies, they don't see a potential upside in very awesome information in terms of short interest. The utilization is insane so for the past seven days, the utilization of available lendable short shares has been maxed out, meaning that 100 of total lendable short shares are currently being held.

In short positions, costs to borrow extremely high 23.85 percent annual interest being accrued. This this number goes up when the risk uh, for these short positions goes up as well right because they want to keep their end of the deal. So that is significant information days to cover is low right. We want to ideally see this number over one.

It doesn't necessarily mean that shorts need to cover their position in 0.37 days right, because shorts can cover whenever they want, as long as they don't get a margin call right options expire. So that's the difference there, but if this is a higher number that decent cover is higher, it means it's a more bullish territory, it's more difficult for shorts to cover their positions in a stock, so uh. This is the only dinger that i'm seeing right now. I ideally would like to see the data cover number being a little bit higher, but keep in mind that this is based off of three month daily volume.

So if we look at the three month chart here, the volume has actually changed uh, i would say pretty drastically right. So if we were to just take out completely the last month of data here, that would exponentially change the picture. I think the data cover would actually be a lot higher, so keep that in the back of your mind when looking at the days to cover number. But that is what it is at the end of the day.

So i do want to point that out to you, the utilization rate is absolutely insane, which leads me to believe that there is some solid, short-term potential for a a small squeeze, not even a small squeeze. It could be a pretty major squeeze on this stock. So if you are looking to get into this position, what is it looking like right? Well, if we just drop a quick fibonacci retracement in terms of the strength of the chart, we saw a pretty nice bounce off. That 61.8 retracement, ideally, would like to see.

50.. 50 is a great great bounce off of a level of support right. That shows a lot of buyer strength, but 61.8 percent is not bad either right. We ideally look for 50 or more, but it did see a nice bounce.

We didn't get that engulfing candlestick pattern, which you can see right here, which signifies that we have in fact found the bottom. In my eyes, we have the beginning of a very small double bottom george davia. My name is george w, which is uh. Typically, a sign of uh upcoming bullish run.

So, if you're looking to establish a position in this stock, what is a solid entry point? Looking like? Well, we've got a nice gap here between the 15mm and the 200dma, and something i think worth noting is that you're starting to see the beginning of a little hook out right so a hook out is when you see the two indicators kind of diverge away from Each other right, instead of hooking, in which typically could be a sign of an upcoming bearish run. So i think that you are very likely going to see an upcoming run here with ctrm in the short term um. I would watch for a retest of 1.95 that overlying level of resistance is significant to watch, so keep that in the back of your mind, if you're looking to establish a position, i think that now is a pretty solid time to buy on the r side is Sitting at 45 has been consolidating for the last two days right overall volume, not extremely low uh, the utilization rate extremely high, so there's some pretty solid short term potential here i think a buying around dollar twenty, it's going to treat you pretty dang well here with Ctr m last sock. We're going to talk about here today is ooh me and man, oh what a freaking anomaly of a stock.

Oh, my god, i was going to post a video about this thing guys. I did not feel good about this stock whatsoever. Since i got that sec ding, which we'll talk about here in a minute - but i am very pleasantly surprised that um held up and i'll get into why - i think that is the case. So what do they do? What is the why? Why should you care? There are basic materials, mineral resources, metals and mining and specialty mining and metals company.

They basically play in two different factories here, so they get into. You know a little bit of the autonomous vehicle game because they, the the material, the rare earth metal they use. Antimony, which is what i'm going to talk about here in a second, is used by batteries and autonomous vehicles and electric vehicles. And then there are rare earth metal uh stock as well.

So what do they do? United states? Anti-Money corporation is engaged in the production and sale of antimony, silver, gold and zealot products. The product the company is a mining transportation, milling smelting and marketing company. It has three segments united states, antimony operations, mexican antimony operations and united states zealot operations. Its operations include a smelter and a mellow refinery in montana, and a smell turned over three mills in mexico.

It operates through antimony division and zelda division. Its antimony, smelter in metal plants, is located in the burns mining district of sanders county montana. It also sells antimony metal for use in bearing storage batteries and ordnance. The property includes over two five acre mill.

Sites bears a bear: river zealot company has zelda in the united states bureau of land management land. The property has over two dryer circuits, one for lines, one and two and one for the raymond mill. Three mill has a rated capacity of over 10 tons per hour. So i'm just going to pull up u.s antimony here, really quick, i'm gon na show you guys their website, which looks like it came uh from the the freaking 1990s uh, very, very old website.

This reminds me a lot of the outdated military websites that i have to use for work, but essentially what they do is they're a us-based company, and that is significant because there has been talk about china, cutting off china. I always have to do that. I always have to do that. Uh about china, cutting off you know exporting to the united states of rare earth, metal materials if that ends up happening, the basic laws of supply and demand.

My friends are going to come into play here. So if you cut off supply, the demand goes up exponentially right. So, if, if whammy is the only company within the united states, as of now from my understanding that is offering this antimony product, the demand for that is going to be so freaking sky high and there's some different things here. That lead us to believe that there's some solid potential for growth here in the future.

So one thing that i do want to show you here is the united states. Antimony fundamentals are improving uh. This is coming from seeking alpha, which does typically come in. In some stocks with a short position but uh, i don't want to show you the summary.

The rare earth and strategic metals have improved outlook due to weaker production in china and increased global demand due in part to battery technology and stockpiling. This has caused many small mining companies such as u.s antimony to boom evidence suggests. The rally in miners, such as whammy, is partly fueled by speculative fervor, which could cause a near-term reversal. Uh u.s, antimony's equity sale will give it a large pile of cash.

They did recently have an equity sale which can be used to expand production and potentially more profitable prices, while us antimony's outlook has improved its valuation today is a bit difficult to justify. So seeking alpha does think that um is a little bit overpriced. Take that for what it is, i want to present all the information to you that i think is is relevant right, but i personally think there's a pretty decent amount of upside. As do other investors, you do need to pay attention to the overall sentiment of the market and, right now the sentiment of the market with whammy is pretty solid and they had an sec ding here, which i think i have an article pulled up here.

Real quick on and we're just gon na read that up so united states animal corporation announces receipt of warning letter from new york stock exchange american. So, let's just take a quick read here: uemi a growing vertically integrated natural resource company yada yada yada received a letter from new york stock exchange regulation, which letter serves as a warning letter, as provided under section 1009 uh the basis for the letters the company sold Shares of its common stock in a manner that violated, section 301 and 713 of the company guide trading in the company's common stock has been halted since before the opening of trading on wednesday february 17th, as new york stock exchange regulation has assessed these rule violations. So essentially, they violated some rules on two non-underwritten transactions involving the sale of 26.2 million total shares. They ended up getting that corrected right, but i thought for sure i thought for ding sure they were gon na see.

This bleed bad and we didn't see that whatsoever, and i think the case for that is two possible scenarios. There's one scenario here, which i think is probably the most likely is overall attention and hype regarding the play right. So i think there was some hype in regards to uh. You know the the attention the amount of people that got eyes on it, so you might have seen a run just because of the fact that more people were paying attention to whammy.

The second scenario for me is going to be uh if i've got the article pulled up here this, which is the potential of an ambry deal, so us antimony, corporation signs, non-binary letter of interest regarding potential, simple supply of antimony with ambry ambry is an institution that Is that is invested in by bill gates? So that's very significant any time that you see those big name guys that are they're getting into deals with small companies that could really really drive the price action up on a stock. So keep that in the back of your mind, that is something i think is very significant to pay attention to the the the institutional ownership i do want to point out to. You is 4.65 about 4, 4.2 million shares, not a significant stake right, and maybe that number is a little bit lagged, but all these numbers aren't from back in 2020 or or earlier than that. So we'll run with the worst case scenario here, which is 4.65.

I look for at least 10 in a company to signify there's a huge uh amount of institutional buying in a company which i think is a positive thing. So that's a box. We have not checked here right. I would ideally like to say that over 10 - that is not the case, but it is possible.

We do see this run down the road, regardless uh, just going to make sure that i've got everything here that i wanted to read off to you or text. Is the last thing? So if we look at ortex and the overall short interest on uamy, it's not very high. Surprisingly, it's actually dropped off a lot here over the last seven days. It is down to fourteen point five, two percent uh.

This is not a stock. That's being heavily shorted, so that means that currently there are eighty-six percent of the total endable short shares available for lending the cost. To borrow is forty two point: eight four percent, which is pretty dang high. That is a significant number.

So that means there's a lot of risk involved for shorts to buy into the stock right now days to cover is low. I would say anything that over one is a significant number to pay attention to indicating that it is difficult for shorts to cover their positions. Profitably this does not necessarily mean that shorts have to cover their position in 0.18 days. This is this is referring to the fact that hey, you know the the overall short interest as compared to the three month.

Average volume is uh saying that it is at the moment, easy for shorts to cover their position profitably, so the higher the number, the more the more difficult it is for shorts to come up profitable and the more bullish a stock will be in nature. So that is how the current numbers are. Looking right there you look here at the charts. There are uh some options here on whammy and probably the most significant thing to pay attention to is this 2.5 strike on 19 march? There is 8 000 total calls on that.

So that's pretty solid as compared to the puts there's not a lot of puts, so the call to put ratio is very, very, very high. So there's quite a bit of sentiment on here. Typically calls and inputs are a great way to get it sort of you know sentiment an idea of what current traders are thinking about a stock and there's a lot of bullish sentiment in regards to whammy. Looking at the charts here, real quick, there is uh some pretty nice volume pumping into this.

We have the sec ding that reopened trading right for a while. They were halted. They were halted from 216 to 219, essentially and uh. We saw a huge push in volume which drive that volatility, so that's pretty significant.

I do also want to point out that the 15 m8 is starting to you, know, gap away from the 200 ema we're starting to see that kind of open up, and that is also a solid thing. So when you see these two trend lines diverge from each other, that is typically, you know, an indicator of an upcoming possible bullish, run uh nice big gap here between the 15 mm and the 200 dma. If you got into the stock back when i recommended it, when the 59 was starting to gap away back here, about 87 cents, you'd be sitting god dang filthy right now, and that is looking absolutely beautiful in terms of retracements. This stock has been very very nice.

It has not been bad at all 38.2 retracement, which is almost picture perfect honestly, and this retracement, you know with the extra volatility and volume was not quite as good to us. It did retrace about 78.6 percent, but if you do exclude this candlewick, since there was insane volatility at the market open, you can see that it actually retraced to about. I think that is 50 61.8, so not a terrible retracement. I do think it is pretty likely that this is going to continue its run.

If you are looking for an entry point, what is the best possible point for you to get into this stock? Well, i do think, as it sits now, that 192 level is gon na, be pretty solid, a pretty solid entry point. So if you see this dip under two bucks right, i think that's gon na be a pretty solid entry point. You can get within a couple cents that entry point. That is going to be what i would look for in terms of the the the way to get into whammy right.

.